Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.


The Polycomb group and oncogene Bmi1 is required for the proliferation of various differentiated cells and for the self-renewal of stem cells and leukemic cancer stem cells. Repression of the Ink4a/Arf locus is a well described mechanism through which Bmi1 can exert its proliferative effects. However, we now demonstrate in an orthotopic transplantation model for glioma, a type of cancer harboring cancer stem cells, that Bmi1 is also required for tumor development in an Ink4a/Arf-independent manner. Tumors derived from Bmi1;Ink4a/Arf doubly deficient astrocytes or neural stem cells have a later time of onset and different histological grading. Moreover, in the absence of Ink4a/Arf, Bmi1-deficient cells and tumors display changes in differentiation capacity.

More about this publication

Cancer cell
  • Volume 12
  • Issue nr. 4
  • Pages 328-41
  • Publication date 01-10-2007

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.